drugset / Trial / NCT00760968
Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the efficacy and safety of TAK-783, once daily (QD), taken in combination with methotrexate in subjects with rheumatoid arthritis.
Timeline
- Start
- 2007-08
- Primary completion
- 2009-02
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TAK-783 | Unknown | 100 mg | Oral |
| Comparator | Methotrexate | Small molecule | — | — |